Squarepoint’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $79.2K | Sell |
|
|||||
|
2025
Q2 | $90.4K | Sell |
|
|||||
|
2025
Q1 | $90K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $296K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $67.8K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $58.2K | Sell |
|
|||||
|
2022
Q4 | $52.1K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $55K | Sell |
|
|||||
|
2021
Q4 | $153K | Buy |
|
|||||
|
2021
Q3 | $59K | Sell |
|
|||||
|
2021
Q2 | $59K | Sell |
|
|||||
|
2021
Q1 | $514K | Buy |
|
|||||
|
2020
Q4 | $53K | Sell |
|
|||||
|
2020
Q3 | $242K | Buy |
|
|||||
|
2020
Q2 | $277K | Sell |
|
|||||
|
2020
Q1 | $510K | Buy |
|
|||||
|
2019
Q4 | $439K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $346K | Sell |
|
|||||
|
2019
Q1 | $415K | Buy |
|
|||||
|
2018
Q4 | $173K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $171K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $179K | Sell |
|
|||||
|
2017
Q2 | $272K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $195K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $215K | Sell |
|
|||||
|
2015
Q4 | $353K | Buy |
|